Nile Pharma’s net profit increases 10.4% YoY in 6 months

El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) recorded a year-on-year (YoY) net profit increase of 10.4% in the first half (H1) of the fiscal year (FY) 2022/2023, according to the financial statement sent to the EGX.

The company’s net profit after tax amounted EGP 46.413 million for the six-month period ended in December 31th 2022, compared to EGP 42.052 million in the same period of the previous fiscal year.

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.